Trial intelligence / Profile preview

Sertraline in maintenance hemodialysis patients with depression

NCT06124417Phase 4Completed

Sponsor
First Affiliated Hospital of Chongqing Medical University
Start
Jan 2022
Primary completion
Aug 2023
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of sertraline in major depressive disorder (MDD), sponsored by First Affiliated Hospital of Chongqing Medical University. Started Jan 2022; status: completed.

02

Drugs

sertraline
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NCT06124417.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06124417.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call